About Us | Nuevocor
At Nuevocor, our mission is to revolutionize the treatment of untreatable cardiomyopathies by embracing an innovative mechanobiology-centered approach. Nuevocor’s lead program NVC-001 is a genetic medicine to treat patients suffering from lamin dilated cardiomyopathy. Presently, the only recourse for these patients is a costly and often elusive cardiac transplant. With operations in both Singapore and the United States, Nuevocor focuses on developing innovative first-in-class mechanobiology-based genetic medicines for heart conditions known as genetic cardiomyopathies.
Verified
ASGCT22 | Nuevocor
Nuevocor Founders to Present at the American Society of Gene and Cell Therapy (ASGCT) 2022 Meeting
View all products
Keywords
Industries
City: San Jose
State: Nueva Ecija
Country: Philippines
Where is Nuevocor located?
The company Nuevocor is located in San Jose, Nueva Ecija, Philippines. It's worth noting that the company may has more corporate locations
When was Nuevocor founded?
Nuevocor was founded in 2020
In which industries does Nuevocor mainly work?
The company Nuevocor has it's main focus in the industries of Biotechnology, Health Care, Science and Engineering
Regencor
United States
Neocardial Technologies
United States
1-10 Employees
Imbria Pharmaceuticals
United States
11-50 Employees
2018
Tenaya Therapeutics
United States
11-50 Employees
2016
BioCardia
United States
11-50 Employees
1999
Novoheart Holdings
Canada
51-100 Employees
1964
Vicore Pharma
Sweden
1-10 Employees
2009
Helios Cardio
United States
1-10 Employees
Topics which have been searched by others and may be interesting for you:
